Related Experiment Videos
Trinucleotide repeats and neurodegenerative disease
1Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, UK.
Brain : a Journal of Neurology
|August 27, 2004
Summary
Trinucleotide repeat disorders involve toxic protein gain in polyglutamine diseases and unclear mechanisms in untranslated repeats, leading to neuronal death. Research shows progress in models, but these neurodegenerative diseases remain irreversible.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Trinucleotide repeat disorders are a class of neurodegenerative diseases.
- Recent advances have clarified the molecular pathology, enabling subclassification.
Purpose of the Study:
- To review the molecular pathology of trinucleotide repeat neurodegenerative diseases.
- To differentiate between translated polyglutamine diseases and untranslated repeat disorders.
- To discuss potential therapeutic interventions.
Main Methods:
- Genetic definition and subclassification.
- Analysis of molecular pathogenic mechanisms.
- Review of cellular and animal models.
Main Results:
- Polyglutamine disorders result from toxic gain of function of expanded proteins, leading to neuronal intranuclear inclusions (NIIs), protein misfolding, and apoptosis.
- Mechanisms for untranslated repeat disorders are less clear, involving DNA structures, chromatin modification, and RNA dysfunction.
- Progress in arresting and reversing neurodegeneration is noted in cellular and animal models.
Conclusions:
- Understanding molecular mechanisms is crucial for future therapeutic strategies.
- Trinucleotide repeat neurodegenerative diseases currently remain irreversible.
- Further research into untranslated repeat disorders is needed.